Substipharm
Substipharm, a leading player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe. Founded in 2008, the company has established itself as a key provider of high-quality generic and specialty medicines, focusing on therapeutic areas such as oncology, cardiology, and neurology. With a commitment to innovation, Substipharm offers a unique portfolio of products that cater to the evolving needs of healthcare professionals and patients alike. The company’s dedication to quality and regulatory compliance has positioned it as a trusted partner in the pharmaceutical sector. Notable achievements include successful partnerships with various healthcare organisations, enhancing its market presence and reputation for excellence in drug development and distribution.
DitchCarbon Score
How does Substipharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Substipharm's score of 16 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Substipharm's reported carbon emissions
Substipharm, headquartered in France, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that Substipharm has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability and carbon neutrality, it will be essential for Substipharm to establish clear climate commitments and reduction initiatives to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Substipharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
